Sanofi (EPA:SANNV)

Market Cap	97.99B -25.6%
Revenue (ttm)	46.72B +5.5%
Net Income	7.81B +40.5%
EPS	6.37 +43.6%
Shares Out	n/a
PE Ratio	12.54
Forward PE	9.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,602
Average Volume	n/a
Open	106.28
Previous Close	105.20
Day's Range	103.42 - 106.50
52-Week Range	82.72 - 106.50
Beta	n/a
RSI	n/a
Earnings Date	Apr 23, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for onc...

• Industry: Drug Manufacturers - Major
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: Euronext Paris
• Ticker Symbol: SANNV

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.